Therapeutic efficacy and safety of Compound Kushen Injection combined with transarterial chemoembolization in unresectable hepatocellular carcinoma: An update systematic review and meta-analysis

• मुख्य लेखकों: Xiao eMa (लेखक), Ruisheng eLi (लेखक), Jian eWang (लेखक), Yinqiu eHuang (लेखक), Pengyan eLi (लेखक), Ji eWang (लेखक), Haibin eSu (लेखक), Ruilin eWang (लेखक), Yaming eZhang (लेखक), Honghong eLiu (लेखक), Congen eZhang (लेखक), Zhijie eMa (लेखक), Jiabo eWang (लेखक), Yanling eZhao (लेखक), Xiaohe eXiao (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2016-03-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Background: Compound Kushen Injection (CKI) is a Chinese patent medicine approved by the Chinese State Food and Drug Administration for the treatment of various types of solid tumors. CKI, combined with transarterial chemoembolization (TACE), is believed to increase the therapeutic efficacy of unres...